Company: DVAX
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001029142-25-000071
Chunk: 216

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 216
---
, net of statutory tax withholdings9951--(8,160)--(8,159)Issuance of common stock under Employee Stock Purchase Plan94---904--904Stock compensation expense----13,014--13,014Total other comprehensive loss-----(2,265)-(2,265)Net loss------(8,721)(8,721)Balances at March 31, 2024130,859$131 -$- $1,562,027 $(4,373)$(939,305)$618,480 

See accompanying notes.

7

Table of Contents

Dynavax Technologies Corporation 

Condensed Consolidated Statements of Cash Flows 

(In thousands) 

(Unaudited) 

Three Months Ended March 31,20252024Operating activitiesNet loss$(96,099)$(8,721)Adjustments to reconcile net loss to net cash used in operating activities:    Depreciation and amortization1,173 1,124 Amortization of right-of-use assets863 824 Inventory write off3,976 1,264 Sublease termination loss (Note 5)- 4,765 Accretion of discounts on marketable securities(2,137)(4,528)Stock-based compensation expense14,455 13,014 Bad debt expense (Note 6)10,970 - Non-cash interest expense1,691 1,695 Loss on debt extinguishment82,095 - Changes in operating assets and liabilities:    Accounts and other receivables, net(9,651)(1,621)Inventories(8,325)(9,780)Prepaid expenses and other current assets(5,518)(4,682)Accounts payable(4,668)(2,640)Lease liabilities(1,101)(1,025)Accrued and other liabilities(7,363)(6,368)Net cash used in operating activities(19,639)(16,679)Investing activities    Purchases of marketable securities(93,697)(150,685)Proceeds from maturities and redemption of marketable securities104,535 154,265 Purchases of property and equipment, net(3,928)(749)Net cash provided by investing activities6,910 2,831 Financing activities    Proceeds from issuance of Convertible Notes (Note 7)39,708 - Payment for debt issuance costs